What can plan sponsors do about the rising costs of their drug plans? Participants at the Face to Face in Drug Plan Management Forum in Vancouver heard about some of the solutions. From boosting adherence to options for plan redesign, the sessions highlighted many of the solutions available to plan sponsors. The conference, which took place on May 2 at the Fairmont Waterfront Hotel in Vancouver, also tackled some of the widely held myth about drugs and benefits plans.
Photos from the event are available in our photo gallery.
Here are the highlights of the sessions:
Panel explores solutions to boost adherence
Non-compliance with prescription medications is a huge concern for drug plan sponsors who worry about wasting money and worsened outcomes for their members. A panel at the recent Face to Face in Drug Plan Management conference in Vancouver explored the reasons for non-adherence and offered up solutions.
Read more
A look at the prevalence of cost-control measures in private drug plans
With big escalations in drug plan costs year after year, many plan sponsors want to get a better grip on spending. But how can drug plans better manage costs without restricting members’ access to the medications they need?
Read more
Tackling common myths in drug plan management
What are some of the common myths and misconceptions in drug plan management? Panellists explored the issues during the recent Face to Face in Drug Plan Management conference held in Vancouver.
Read more
What’s the impact of medical marijuana on patients, drug plans?
With increasing use of cannabis for therapeutic purposes and legalization pending for recreational use, many employers are wondering about the implications for their drug plans and the health of their employees.
Read more